öktem, a. Et Al. 2016. Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy. EXPERIMENTAL DERMATOLOGY , vol.10 , 1-5.

öktem, a., AKAY, B. N., BOYVAT, A., KUNDAKCI, N., ERDEM, C., BOSTANCI, S., ... ŞANLI, H.(2016). Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy. EXPERIMENTAL DERMATOLOGY , vol.10, 1-5.

öktem, ayşe Et Al. "Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy," EXPERIMENTAL DERMATOLOGY , vol.10, 1-5, 2016

öktem, ayşe Et Al. "Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy." EXPERIMENTAL DERMATOLOGY , vol.10, pp.1-5, 2016

öktem, a. Et Al. (2016) . "Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy." EXPERIMENTAL DERMATOLOGY , vol.10, pp.1-5.

@article{article, author={ayşe öktem Et Al. }, title={Long term results of rituximab intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita reistant to conventional therapy}, journal={EXPERIMENTAL DERMATOLOGY}, year=2016, pages={1-5} }